| __timestamp | Geron Corporation | MannKind Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 16758000 | 79383000 |
| Thursday, January 1, 2015 | 17793000 | 108402000 |
| Friday, January 1, 2016 | 18761000 | 46928000 |
| Sunday, January 1, 2017 | 19287000 | 74959000 |
| Monday, January 1, 2018 | 18707000 | 79716000 |
| Tuesday, January 1, 2019 | 20893000 | 74669000 |
| Wednesday, January 1, 2020 | 25678000 | 59040000 |
| Friday, January 1, 2021 | 29665000 | 77417000 |
| Saturday, January 1, 2022 | 43628000 | 91473000 |
| Sunday, January 1, 2023 | 69135000 | 94314000 |
Cracking the code
In the ever-evolving landscape of biotechnology, operational efficiency is paramount. Over the past decade, Geron Corporation and MannKind Corporation have showcased contrasting strategies in managing their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, MannKind consistently outpaced Geron, with SG&A expenses peaking at nearly 94 million in 2023, a 19% increase from 2014. In contrast, Geron saw a dramatic rise, with expenses surging by over 300% to approximately 69 million in the same period. This divergence highlights MannKind's steady investment in operational activities, while Geron appears to be ramping up its efforts more recently. As these companies navigate the competitive biotech sector, their SG&A trends offer a window into their strategic priorities and financial health.
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or MannKind Corporation
SG&A Efficiency Analysis: Comparing Takeda Pharmaceutical Company Limited and Geron Corporation
SG&A Efficiency Analysis: Comparing Viatris Inc. and MannKind Corporation
Dr. Reddy's Laboratories Limited and MannKind Corporation: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Halozyme Therapeutics, Inc. or MannKind Corporation
Madrigal Pharmaceuticals, Inc. and Geron Corporation: SG&A Spending Patterns Compared
Arrowhead Pharmaceuticals, Inc. and Geron Corporation: SG&A Spending Patterns Compared
ImmunityBio, Inc. or Geron Corporation: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Agios Pharmaceuticals, Inc. vs Geron Corporation
Geron Corporation or Novavax, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: MannKind Corporation vs Travere Therapeutics, Inc.
MannKind Corporation and Novavax, Inc.: SG&A Spending Patterns Compared